UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abstract P5-11-18: Real-world evidence of efficacy and activity of palbociclib plus endocrine therapy and post-progression treatments in HR+/HER2- metastatic breast cancer patients: The PALPract study

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P5-P5-11-18

2020

Volltextzugriff (PDF)

Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe , a multicentric, observational study

Frontiers in oncology, 2023-05, Vol.13, p.1152123-1152123

2023

Volltextzugriff (PDF)

Antiangiogenic agents

I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.], 2002-07, Vol.1 (4), p.S39

2002

Volltextzugriff (PDF)

Can a combination of probiotics and nutraceuticals help preventing the abemaciclib-related diarrhea in breast cancer patients?

Minerva Gastroenterology, 2024-06, Vol.70 (2), p.242

2024

Volltextzugriff (PDF)

Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study

International journal of radiation oncology, biology, physics, 1999-09, Vol.45 (2), p.285-289

1999

Volltextzugriff (PDF)

Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study11Data management by Italian Trials in Medical Oncology (I.T.M.O.) Scientific Service

International journal of radiation oncology, biology, physics, 1999-09, Vol.45 (2), p.285-289

1999

Volltextzugriff (PDF)

The combination of the selective cyclooxygenase-2 inhibitor celecoxib with weekly paclitaxel is a safe and active second-line therapy for non-small cell lung cancer: a phase II study with biological correlates

The cancer journal (Sudbury, Mass.), 2005-05, Vol.11 (3), p.209-216

2005

Volltextzugriff (PDF)

Gemcitabine plus vinorelbine as first‐line chemotherapy in advanced nonsmall cell lung carcinoma a Phase II trial

Cancer, 2000-08, Vol.89 (4), p.763-768

2000

Volltextzugriff (PDF)

Induction chemotherapy with carboplatin/paclitaxel followed by surgery or standard radiotherapy and concurrent daily low-dose cisplatin for locally advanced non-small cell lung cancer (NSCLC)

American journal of clinical oncology, 2003-06, Vol.26 (3), p.265-269

2003

Volltextzugriff (PDF)

Phase I study of escalating doses of oxaliplatin in combination with fixed dose gemcitabine in patients with non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2004-02, Vol.43 (2), p.203-208

2004

Volltextzugriff (PDF)

Pregnacy in breast cancer survivors: safety and feasibility

Reviews in Oncology, 2015

Stani, Simonetta Chiara

2015

Volltextzugriff (PDF)

Preoperative chemoradiation in patients with resectable rectal cancer: results on tumor response

Annals of surgical oncology, 2002-06, Vol.9 (5), p.444-449

2002

Volltextzugriff (PDF)

Real-life effectiveness of T-DM1 in heavily pretreated HER2-positive advanced breast cancer patients: An Italian observational study

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e12019-e12019

2016

Volltextzugriff (PDF)

Safety and activity of the combination of pegylated liposomal doxorubicin and weekly docetaxel in advanced breast cancer

Breast cancer research and treatment, 2004-08, Vol.86 (3), p.249-257

2004

Volltextzugriff (PDF)

Second line treatment of antiangiogenic therapy with celecoxib and weekly paclitaxel for advanced non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S181-S181

2003

Volltextzugriff (PDF)

Single-agent chemotherapy with vinorelbine for pretreated or metastatic squamous cell carcinoma of the esophagus

Tumori, 2001-09, Vol.87 (5), p.299-302

2001

Volltextzugriff (PDF)

Ten‐year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus

Cancer, 2002-01, Vol.94 (2), p.352-361

2002

Volltextzugriff (PDF)

Third national surgical consensus conference of the Italian Association of Breast Surgeons (ANISC) on management after neoadjuvant chemotherapy: The difficulty in reaching a consensus

European journal of surgical oncology, 2024-07, Vol.50 (7), p.108351, Article 108351

2024

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Oncology
(13)
Humans
(12)
Female
(11)
Aged
(10)
Middle Aged
(10)
Male
(8)
Adult
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Biological And Medical Sciences
(6)
Medical Sciences
(6)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(5)
Lung Neoplasms - Drug Therapy
(5)
Survival Analysis
(5)
Treatment Outcome
(5)
Chemotherapy
(4)
Combined Modality Therapy
(4)
Surgery
(4)
Antineoplastic Agents
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abstract P5-11-18: Real-world evidence of efficacy and activity of palbociclib plus endocrine therapy and post-progression treatments in HR+/HER2- metastatic breast cancer patients: The PALPract study

Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe , a multicentric, observational study

Antiangiogenic agents

Can a combination of probiotics and nutraceuticals help preventing the abemaciclib-related diarrhea in breast cancer patients?

Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study

Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study11Data management by Italian Trials in Medical Oncology (I.T.M.O.) Scientific Service

The combination of the selective cyclooxygenase-2 inhibitor celecoxib with weekly paclitaxel is a safe and active second-line therapy for non-small cell lung cancer: a phase II study with biological correlates

Efficacy and safety of T-DM1 in the 'common-practice' of HER2+ advanced breast cancer setting: a multicenter study

Gemcitabine plus vinorelbine as first‐line chemotherapy in advanced nonsmall cell lung carcinoma a Phase II trial

Induction chemotherapy with carboplatin/paclitaxel followed by surgery or standard radiotherapy and concurrent daily low-dose cisplatin for locally advanced non-small cell lung cancer (NSCLC)

Phase I study of escalating doses of oxaliplatin in combination with fixed dose gemcitabine in patients with non-small cell lung cancer

Post-Progression Treatments after Palbociclib plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer Patients: What Is the Better Choice?

Pregnacy in breast cancer survivors: safety and feasibility

Preoperative chemoradiation in patients with resectable rectal cancer: results on tumor response

Real-life effectiveness of T-DM1 in heavily pretreated HER2-positive advanced breast cancer patients: An Italian observational study

Safety and activity of the combination of pegylated liposomal doxorubicin and weekly docetaxel in advanced breast cancer

Second line treatment of antiangiogenic therapy with celecoxib and weekly paclitaxel for advanced non-small cell lung cancer (NSCLC)

Single-agent chemotherapy with vinorelbine for pretreated or metastatic squamous cell carcinoma of the esophagus

T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer

Ten‐year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus

Third national surgical consensus conference of the Italian Association of Breast Surgeons (ANISC) on management after neoadjuvant chemotherapy: The difficulty in reaching a consensus

Suchergebnisse filtern